Cloned Antibodies to COVID-19 Virus Show Promise for Therapy and Prevention

Researchers at Tsinghua University in Beijing, China have now successfully cloned antibodies from COVID-19 survivors. In lab tests, the antibodies prevented the virus from binding to its receptor on cells, meaning the antibodies would appear to have prevented the disease. Although promising, it’s still unclear if this would actually prevent infection in people.